BMC Cancer

Papers
(The median citation count of BMC Cancer is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Incidence, survival, and associated factors estimation in osteosarcoma patients with lung metastasis: a single-center experience of 11 years in Tianjin, China173
Brigatinib versus other second-generation ALK inhibitors as initial treatment of anaplastic lymphoma kinase positive non-small cell lung cancer with deep phenotyping: study protocol of the ABP trial114
Geographical variations of cancer incidence in Guadeloupe, French West Indies110
Translation and validation of a simplified Chinese version of the psychosocial assessment tool98
Distinguishing IDH mutation status in gliomas using FTIR-ATR spectra of peripheral blood plasma indicating clear traces of protein amyloid aggregation91
EGR1 mediates MDR1 transcriptional activity regulating gemcitabine resistance in pancreatic cancer88
Adherence to the evidence-based recommendations in managing bone health, pain, and mobility of patients with multiple myeloma: a mixed method in the Palestinian healthcare system86
LABS score– a prognostic tool for FOLFOX4-treated advanced hepatocellular carcinoma and real-world efficacy: a single-center retrospective study84
Clinical characteristics, pregnancy outcomes and ovarian function of pregnancy-associated breast cancer patients: a retrospective age-matched study83
Immune checkpoint inhibitor plus chemotherapy as first-line treatment for non-small cell lung cancer with malignant pleural effusion: a retrospective multicenter study83
Factors associated with recurrence in patients with oral cancer in Mongolia79
Hsa_circ_0004872 alleviates meningioma progression by sponging miR-190a-3p/PTEN signaling79
Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phas78
Smoking-mediated nicotinic acetylcholine receptors (nAChRs) for predicting outcomes for head and neck squamous cell carcinomas67
Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015–201665
MicroRNAs utilization as effective factors on hematopoietic stem cell transplantation, its outcomes and prognosis; a comprehensive systematic review63
Subgroup analyses from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial58
An open-label expanded access program of afatinib in EGFR tyrosine kinase inhibitor-naïve patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR mutations57
The lipid-lowering drug fenofibrate combined with si-HOTAIR can effectively inhibit the proliferation of gliomas54
Blockade of the amino acid transporter SLC6A14 suppresses tumor growth in colorectal Cancer53
Simplification of dosimetry in 90Y-radioembolization therapy by dual planar images51
IMAGENE trial: multicenter, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy of niraparib with PD-1 inhibitor in solid cancer patients with homologous recombi50
The pilot project of the National Cancer Network in Poland: Assessment of the functioning of the National Cancer Network and results from quality indicators for lung cancer (2019–2021)48
Neoadjuvant irradiation of extremity soft tissue sarcoma with ions (Extrem-ion): study protocol for a randomized phase II pilot trial46
Primary tumor resection improves prognosis of unresectable carcinomas of the transverse colon including flexures with liver metastasis: a preliminary population-based analysis46
Simulating the restoration of normal gene expression from different thyroid cancer stages using deep learning46
Pre-operative vs. post-operative stereotactic radiosurgery for operative metastatic brain tumors: study protocol for a phase III clinical trial45
Correction: EGFR-TKIs or EGFR-TKIs combination treatments for untreated advanced EGFR-mutated NSCLC: a network meta-analysis44
Rationale and design of APOLLO: a personalized rehAbilitation PrOgram in aLLOgeneic bone marrow transplantation44
Organ-specific immune-related adverse events and prognosis in cancer patients receiving immune checkpoint inhibitors42
Association between colorectal cancer and arthritis among Americans in 2005–201642
Radiotherapy(R) Integration(I) Strategy for Small(S)-Cell Lung Cancer in Extensive(E) Stage (RISE) with up to 10 metastases- a study protocol of a randomized phase II trial42
Patient satisfaction with radio-frequency identification (RFID) tag localization compared with wire localization for nonpalpable breast lesions: the RFID trial40
External beam radiation therapy versus radical prostatectomy for high-risk prostate cancer: protocol of the RECOVER study40
Resolution of oncogene-induced senescence markers in HPV-infected cervical cancer tissue40
Surgery lengthens survival for collecting duct carcinoma: analysis of hospital-based cancer registry data in Japan39
Meta Analysis of Methylenetetrahydrofolate Reductase (MTHFR) C677T polymorphism and its association with folate and colorectal cancer39
Diagnostic and prognostic values of tsRNAs in lung cancer: a meta-analysis39
Retraction Note: Up-regulated miR-199a-5p in gastric cancer functions as an oncogene and targets klotho38
Fully automated segmentation and classification of renal tumors on CT scans via machine learning38
Percent change in apparent diffusion coefficient and plasma EBV DNA after induction chemotherapy identifies distinct prognostic response phenotypes in advanced nasopharyngeal carcinoma37
A phase II study of gemcitabine and docetaxel combination in relapsed metastatic or unresectable locally advanced synovial sarcoma37
Thoracoscopic three-port single versus multiple intercostal for radical resection of esophageal cancer: a retrospective analysis36
High complement protein C1q levels in pulmonary fibrosis and non-small cell lung cancer associated with poor prognosis36
The survival strength of younger patients in BCLC stage 0-B of hepatocellular carcinoma: basing on competing risk model36
Nomogram to predict overall survival based on the log odds of positive lymph nodes for patients with endometrial carcinosarcoma after surgery35
The impact of the expression level of growth differentiation factor 15 in tumor tissue on the response to immunotherapy in non-small cell lung cancer35
The differential presence of human polyomaviruses, JCPyV and BKPyV, in prostate cancer and benign prostate hypertrophy tissues35
Osteoblastic bone reaction in non-small cell lung cancer harboring epidermal growth factor receptor mutation treated with osimertinib35
Comparison of pathologic response and survival outcomes between neoadjuvant chemoradiotherapy (nCRT) and neoadjuvant immunochemotherapy (nICT) in patients with locally advanced esophageal squamous cel34
Evaluation of the role of KPNA2 mutations in breast cancer prognosis using bioinformatics datasets34
CANT1 serves as a potential prognostic factor for lung adenocarcinoma and promotes cell proliferation and invasion in vitro34
Identification and validation of genes associated with prognosis of cisplatin-resistant ovarian cancer34
Association between processed and ultra-processed food intake and the risk of breast cancer: a case-control study34
Deep learning-based characterization of pathological subtypes in lung invasive adenocarcinoma utilizing 18F-deoxyglucose positron emission tomography imaging34
A clinically applicable model more suitable for predicting malignancy or benignity of pulmonary ground glass nodules in women patients34
Survival benefit of adjuvant TACE for patients with hepatocellular carcinoma and child-pugh B7 or B8 after hepatectomy34
Cell fusion enhances energy metabolism of mesenchymal tumor hybrid cells to sustain their proliferation and invasion34
CT Scans and Cancer Risks: A Systematic Review and Dose-response Meta-analysis33
A population-based validation study of the 8th edition UICC/AJCC TNM staging system for cutaneous melanoma33
Effectiveness of educational intervention on women’s participation to cervical cancer screening: a quasi-experimental study based on PEN-3 model33
Knockdown of CENPM activates cGAS-STING pathway to inhibit ovarian cancer by promoting pyroptosis33
Correlation of gasdermin B staining patterns with prognosis, progression, and immune response in colorectal cancer32
Clinical applications of telemedicine services using a regional telemedicine platform for cancer treatment: a cross-sectional study32
The clinicopathological and prognostic significances of IGF-1R and Livin expression in patients with colorectal cancer32
Randomized phase II study of SOX+B-mab versus SOX+C-mab in patients with previously untreated recurrent advanced colorectal cancer with wild-type KRAS (MCSGO-1107 study)32
Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial32
Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma32
The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma32
Lnc-SELPLG-2:1 enhanced osteosarcoma oncogenesis via hsa-miR-10a-5p and the BTRC cascade32
Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review31
Impact of the preoperative prognostic nutritional index as a predictor for postoperative complications after resection of locally recurrent rectal cancer31
Eslicarbazepine induces apoptosis and cell cycle arrest in C6 glioma cells in vitro and suppresses tumor growth in an intracranial rat model31
Secular trends of morbidity and mortality of prostate, bladder, and kidney cancers in China, 1990 to 2019 and their predictions to 203030
A clinicopathological study and survival analysis of 99 breast cancers with HER2/CEP17 ratio ≥ 2.0 and an average HER2 copy number < 4.0 per cell in China30
The blood level of thioredoxin 1 as a supporting biomarker in the detection of breast cancer30
Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction30
Clinical outcomes in patients relapsed/refractory after ≥2 prior lines of therapy for follicular lymphoma: a systematic literature review and meta-analysis30
Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lung30
Single-copy Snail upregulation causes partial epithelial-mesenchymal transition in colon cancer cells30
Clinical and genomic features in patients with second primary glioblastoma following first primary renal cell carcinoma29
Hsa-miR-181a-5p, hsa-miR-182-5p, and hsa-miR-26a-5p as potential biomarkers for BCR-ABL1 among adult chronic myeloid leukemia treated with tyrosine kinase inhibitors at the molecular response29
Effects of once-yearly zoledronic acid on bone density and incident vertebral fractures in nonmetastatic castration-sensitive prostate cancer patients with osteoporosis29
Tumor response as defined by iRECIST in gastrointestinal malignancies treated with PD-1 and PD-L1 inhibitors and correlation with survival29
Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up29
Pre-diagnostic anti-EBV antibodies and primary liver cancer risk: a population-based nested case-control study in southern China29
Innovative mouse models for the tumor suppressor activity of Protocadherin-10 isoforms28
Long-term survival after neoadjuvant therapy for triple-negative breast cancer under different treatment regimens: a systematic review and network meta-analysis28
Transcriptomic and functional analysis of ANGPTL4 overexpression in pancreatic cancer nominates targets that reverse chemoresistance28
Stemness-related LncRNA pair signature for predicting therapy response in gastric cancer28
Predictive nomograms based on gamma-glutamyl transpeptidase to prealbumin ratio for prognosis of hepatocellular carcinoma patients without microvascular invasion28
Aberrant methylation in neurofunctional gene serves as a hallmark of tumorigenesis and progression in colorectal cancer28
CXCL10 serves as a potential serum biomarker complementing SCC-Ag for diagnosing cervical squamous cell carcinoma28
Associations between modifiable risk factors and hepatocellular carcinoma: a trans-ancestry Mendelian randomization study28
Breast cancer quality of care in Syria: screening, diagnosis, and staging27
Long-term treatment patterns and survival in metastatic breast cancer by intrinsic subtypes – an observational cohort study in Sweden27
Family resilience and its influencing factors among advanced cancer patients and their family caregivers: a multilevel modeling analysis27
Ferroptosis-related lncRNA NRAV affects the prognosis of hepatocellular carcinoma via the miR-375-3P/SLC7A11 axis27
Characteristics and chronologically changing patterns of late-onset breast cancer in Korean women of age ≥ 70 years: A hospital based-registry study27
The comparison of pure uterine serous carcinoma and mixed tumor with serous component: a single-institution review of 91 cases26
Multi-region sampling with paired sample sequencing analyses reveals sub-groups of patients with novel patient-specific dysregulation in Hepatocellular Carcinoma26
The epidemiology of multiple primary cancers in Belgium (2004–2017): Incidence, proportion, risk, stage and impact on relative survival estimates26
A CTLA-4 blocking strategy based on Nanobody in dendritic cell-stimulated cytokine-induced killer cells enhances their anti-tumor effects26
Glioma angiogenesis is boosted by ELK3 activating the HIF-1$$\alpha$$/VEGF-A signaling axis26
The combination of serum oligosaccharide chain (G-test), alpha-fetoprotein, and aspartate aminotransferase to alanine aminotransferase ratio provides the optimal diagnostic value for early detection o26
Survival comparison of first-line treatment regimens in patients with braf-mutated advanced colorectal cancer: a multicenter retrospective study26
Eukaryotic initiation factor 4 A-3 promotes glioblastoma growth and invasion through the Notch1-dependent pathway26
Feasibility and thematic analysis of narrative visualization materials with physical activity monitoring among breast cancer survivors25
Utility of bronchoscopically obtained frozen cytology pellets for next-generation sequencing25
Alternating electric fields can improve chemotherapy treatment efficacy in blood cancer cell U937 (non-adherent cells)25
Retrospective validation study of an artificial neural network-based preoperative decision-support tool for noninvasive lymph node staging (NILS) in women with primary breast cancer (ISRCTN14341750)25
A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and platinum-based chemotherap25
Novel model integrating computed tomography-based image markers with genetic markers for discriminating radiation pneumonitis in patients with unresectable stage III non-small cell lung cancer receivi25
An exploratory study for tuft cells in the breast and their relevance in triple-negative breast cancer: the possible relationship of SOX925
Holmium laser-assisted laparoscopic partial cystectomy for bladder cancer: a single-institutional pilot study with technical feasibility and short-term oncological outcome25
Comprehensive analysis of cancer of unknown primary and recommendation of a histological and immunohistochemical diagnostic strategy from China25
Identification of stemness-related glycosylation changes in head and neck squamous cell carcinoma25
Corticosteroid switch from prednisone to dexamethasone in metastatic castration-resistant prostate cancer patients with biochemical progression on abiraterone acetate plus prednisone25
Atovaquone inhibits colorectal cancer metastasis by regulating PDGFRβ/NF-κB signaling pathway25
TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis25
Increased expression of Nrf2 and elevated glucose uptake in pheochromocytoma and paraganglioma with SDHB gene mutation25
Systematic literature review of real-world evidence for treatments in HR+/HER2- second-line LABC/mBC after first-line treatment with CDK4/6i25
A novel gene expression signature-based on B-cell proportion to predict prognosis of patients with lung adenocarcinoma25
Controlling Nutritional Status (CONUT) score is a prognostic marker in III-IV NSCLC patients receiving first-line chemotherapy25
Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in liver metastasis lesions after colon radical operation25
MTF1 genetic variants are associated with lung cancer risk in the Chinese Han population24
Recurrence of oral squamous cell carcinoma in surgically treated patients at Khartoum Teaching Dental Hospital retrospective cross-sectional study24
Chemotherapy dose per kilogram lean body mass increased dose-limiting toxicity event in male head and neck cancer with taxane and platinum-based induction therapy24
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial24
Molecular and clinical characterization of PTRF in glioma via 1,022 samples24
Digital gene expression analysis of NSCLC-patients reveals strong immune pressure, resulting in an immune escape under immunotherapy24
Anlotinib alone or in combination with bevacizumab in the treatment of recurrent high-grade glioma: a prospective single-arm, open-label phase II trial24
A novel inflammation-nutrition biomarker score for predicting prognosis of patients with cancer: results from a multicenter study23
Optimal treatment strategies for hepatoid adenocarcinoma of the lung: insights from a comprehensive analysis23
Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: fi23
Disparity in cognitive factors related to cancer screening uptake based on the theory of planned behavior23
IKBIP promotes tumor development via the akt signaling pathway in esophageal squamous cell carcinoma23
Clinical value of circulating tumor cells and hematological parameters in 617 Chinese patients with colorectal cancer: retrospective analysis23
Impacts of the SOAT1 genetic variants and protein expression on HBV-related hepatocellular carcinoma23
Identification on surrogating overall survival with progression-free survival of first-line immunochemotherapy in advanced esophageal squamous cell carcinoma—an exploration of surrogate endpoint23
Construction of a comprehensive predictive model for axillary lymph node metastasis in breast cancer: a retrospective study23
Network Evolution Model-based prediction of tumor mutation burden from radiomic-clinical features in endometrial cancers23
Association of progesterone receptor status with 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer23
A necroptosis-related gene signature to predict prognosis and immune features in hepatocellular carcinoma23
Up-regulation of DGAT1 in cancer tissues and tumor-infiltrating macrophages influenced survival of patients with gastric cancer23
A study protocol of a randomized phase II trial of perioperative chemoimmunotherapy verses perioperative chemoimmunotherapy plus preoperative chemoradiation for locally advanced gastric (G) or gastroe23
Breast cancer preventive practices and associated factors among reproductive age women in Wadila District, North East Ethiopia: community based cross-sectional study23
Circulating levels of IL-6 and TGF-β1 in patients with prostate cancer undergoing radiotherapy: associations with acute radiotoxicity and fatigue symptoms23
The effect of HPV DNA and p16 status on the prognosis of patients with hypopharyngeal carcinoma: a meta-analysis23
Lymphocyte migration regulation related proteins in urine exosomes may serve as a potential biomarker for lung cancer diagnosis22
Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer22
Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma22
A text-mining approach to study the real-world effectiveness and potentially fatal immune-related adverse events of PD-1 and PD-L1 inhibitors in older patients with stage III/IV non-small cell lung ca22
POstmastectomy radioThErapy in Node-posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a study protocol for a multicenter prospective phase III randomized controlle22
Results from a real-world study: a novel glycosyltransferase risk score for prognosis, tumor microenvironment phenotypes and immunotherapy in bladder cancer22
Serum beta2-microglobulin acts as a biomarker for severity and prognosis in glioma patients: a preliminary clinical study22
Regulation of KLRC and Ceacam gene expression by miR-141 supports cell proliferation and metastasis in cervical cancer cells22
Enrichment of colibactin-associated mutational signatures in unexplained colorectal polyposis patients22
Astragaloside IV inhibits cell viability and glycolysis of hepatocellular carcinoma by regulating KAT2A-mediated succinylation of PGAM122
A radiomics signature derived from CT imaging to predict MSI status and immunotherapy outcomes in gastric cancer: a multi-cohort study22
MEX3C as a potential target for hepatocellular carcinoma drug and immunity: combined therapy with Lenvatinib22
LINC00511 enhances LUAD malignancy by upregulating GCNT3 via miR-195-5p22
Adapting MultiPLe behavior Interventions that eFfectively Improve (AMPLIFI) cancer survivor health: program project protocols for remote lifestyle intervention and assessment in 3 inter-related random22
Real-world management and outcomes of older patients with locally advanced esophageal squamous cell carcinoma: a multicenter retrospective study22
Aspirin or statin use in relation to survival after surgery for esophageal cancer: a population-based cohort study22
Feasibility and potential effectiveness of nurse-led video-coaching interventions for childhood, adolescent, and young adult cancer survivors: the REVIVER study21
Benefit of a flash dose of corticosteroids in digestive surgical oncology: a multicenter, randomized, double blind, placebo-controlled trial (CORTIFRENCH)21
Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancer21
Lung cancer survival by immigrant status: a population-based retrospective cohort study in Ontario, Canada21
Real-world practice of conversion surgery for unresectable hepatocellular carcinoma - a single center data of 26 consecutive patients21
Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers21
ATF2 loss promotes 5-FU resistance in colon cancer cells via activation of the ATR-Chk1 damage response pathway21
Lactate receptor GPR81 drives breast cancer growth and invasiveness through regulation of ECM properties and Notch ligand DLL421
The association of minerals intake in three meals with cancer and all-cause mortality: the U.S. National Health and Nutrition Examination Survey, 2003–201421
Transcriptome sequencing and multi-plex imaging of prostate cancer microenvironment reveals a dominant role for monocytic cells in progression21
Exploration of the role of Cuproptosis genes and their related long non-coding RNA in clear cell renal cell carcinoma: a comprehensive bioinformatics study21
Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification21
Baseline blood count levels increase odds of cytopenia among CML patients in Kenya: a case control study21
APE1 may influence CD4+ naïve T cells on recurrence free survival in early stage NSCLC21
Impact of the line of treatment on progression-free survival in patients treated with T-DM1 for metastatic breast cancer21
Up-regulation expression and prognostic significance of Syntaxin4 in kidney renal clear cell carcinoma21
AC010883.5 promotes cell proliferation, invasion, migration, and epithelial-to-mesenchymal transition in cervical cancer by modulating the MAPK signaling pathway21
Prognostic biomarker SGSM1 and its correlation with immune infiltration in gliomas20
Construction of CeRNA regulatory network based on WGCNA reveals diagnosis biomarkers for colorectal cancer20
Clinical outcome predictors for metastatic renal cell carcinoma: a retrospective multicenter real-life case series20
Valuable insights from the epacadostat plus pembrolizumab clinical trials in solid cancers20
Estrogen-related genes for thyroid cancer prognosis, immune infiltration, staging, and drug sensitivity20
Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancreatic cancer20
The clinical features and prognosis of patients with mucinous breast carcinoma compared with those with infiltrating ductal carcinoma: a population-based study20
Predictive value of number of metastatic lymph nodes and lymph node ratio for prognosis of patients with FIGO 2018 stage IIICp cervical cancer: a multi-center retrospective study20
The role of AKR1 family in tamoxifen resistant invasive lobular breast cancer based on data mining20
INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gas20
Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma20
Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma20
Pembrolizumab with platinum-based chemotherapy with or without epacadostat as first-line treatment for metastatic non-small cell lung cancer: a randomized, partially double-blind, placebo-controlled p20
Cancer risk in persons with new-onset anaemia: a population-based cohort study in Denmark20
Prognostic value of IDH2R140 and IDH2R172 mutations in patients with acute myeloid leukemia: a systematic review and meta-analysis20
The course of health-related quality of life after the diagnosis of childhood cancer: a national cohort study20
Development and validation of a nomogram for predicting overall survival in patients with sinonasal mucosal melanoma20
Fully semantic segmentation for rectal cancer based on post-nCRT MRl modality and deep learning framework20
Prediction of the local treatment outcome in patients with oropharyngeal squamous cell carcinoma using deep learning analysis of pretreatment FDG-PET images20
Radiation-irritated skin and hyperpigmentation may impact the quality of life of breast cancer patients after whole breast radiotherapy20
Preoperative prognostic nutritional index predicts postoperative infectious complications and oncological outcomes after hepatectomy in intrahepatic cholangiocarcinoma20
Long non-coding RNA BRE-AS1 inhibits the proliferation, migration, and invasion of cancer cells in triple-negative breast cancer and predicts patients’ survival by downregulating miR-2120
High USP32 expression contributes to cancer progression and is correlated with immune infiltrates in hepatocellular carcinoma20
Perioperative outcomes and continence following robotic-assisted radical cystectomy with mainz pouch II urinary diversion in patients with bladder cancer20
Genetic and clinical landscape of ER + /PR- breast cancer in China20
Dietary advanced glycation end products are associated with an increased risk of breast cancer in Iranian adults20
Development of a prognostic signature for esophageal cancer based on nine immune related genes20
Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events19
The association between organised colorectal cancer screening strategies and reduction of its related mortality: a systematic review and meta-analysis19
Hepatocellular carcinoma immune prognosis score predicts the clinical outcomes of hepatocellular carcinoma patients receiving immune checkpoint inhibitors19
High SNHG expression may predict a poor lung cancer prognosis based on a meta-analysis19
Significance of the neutrophil-to-lymphocyte ratio in predicting the response to neoadjuvant chemotherapy in extremity osteosarcoma: a multicentre retrospective study19
KAZN as a diagnostic marker in ovarian cancer: a comprehensive analysis based on microarray, mRNA-sequencing, and methylation data19
Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort19
Stimulating TAM-mediated anti-tumor immunity with mannose-decorated nanoparticles in ovarian cancer19
Sex disparity, prediagnosis lifestyle factors, and long-term survival of gastric cancer: a multi-center cohort study from China19
High ratio of pCXCR4/CXCR4 tumor infiltrating immune cells in primary high grade ovarian cancer is indicative for response to chemotherapy19
Clinicopathological features and prognostic significance of C5aR in human solid tumors: a Meta-analysis19
Identification of CD8+ T-cell exhaustion signatures for prognosis in HBV-related hepatocellular carcinoma patients by integrated analysis of single-cell and bulk RNA-sequencing19
MLXIPL promotes the migration, invasion, and glycolysis of hepatocellular carcinoma cells by phosphorylation of mTOR19
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy with or without nimotuzumab in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study19
Vaginal CO2 laser therapy for genitourinary syndrome in breast cancer survivors—VagLaser study protocol: a randomized blinded, placebo-controlled trial19
Is it sufficient to evaluate metastatic bone involvement in breast cancer using SPECT/CT? A new approach of SPECT/CT-guided targeted bone marrow biopsy19
Nomogram incorporating prognostic immune-inflammatory-nutritional score for survival prediction in pancreatic cancer: a retrospective study19
Analysis of characteristics of peripheral blood lymphocytes in endometrial carcinoma: a single-center study based on five-year clinical data19
Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer19
Safety and feasibility of ultra-long construct navigated minimally invasive spine surgery with adjuvant radiotherapy in extensive spinal metastasis : a comparative analysis19
Hepatic passaging of NRAS-mutant melanoma influences adhesive properties and metastatic pattern19
Nomogram-based development and evaluation for predictions of 30-day and 1-year survival in patients with spontaneously ruptured hepatocellular carcinoma19
Suboptimal use of hormonal therapy among German men with localized high-risk prostate Cancer during 2005 to 2015: analysis of registry data19
Identification of FOXP1 as a favorable prognostic biomarker and tumor suppressor in intrahepatic cholangiocarcinoma19
Patient-reported outcomes in individuals with advanced gastrointestinal stromal tumor treated with ripretinib in the fourth-line setting: analysis from the phase 3 INVICTUS trial19
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC19
The association of E2F1 and E2F2 single nucleotide polymorphisms with laryngeal squamous cell carcinoma pathomorphological features19
Improving power in PSA response analyses of metastatic castration-resistant prostate cancer trials19
Targeting cellular plasticity: esculetin-driven reversion of stem cell-like characteristics and EMT phenotype in transforming cells with sequential p53/p73 knockdowns19
Association between psychiatric disorders and glioma risk: evidence from Mendelian randomization analysis19
Type 2-like polarization and elevated CXCL4 secretion of monocyte derived macrophages upon internalization of plasma-derived exosomes from head and neck cancer patients19
Adipogenesis biomarkers as the independent predictive factors for breast cancer recurrence: a systematic review and meta-analysis19
Cardiac and obstetric outcomes of pregnancies for women after cardiotoxic therapy in childhood: a single center observational study19
Estimating smoking-attributable lung cancer mortality in Chinese adults from 2000 to 2020: a comparison of three methods19
The survivin-ran inhibitor LLP-3 decreases oxidative phosphorylation, glycolysis and growth of neuroblastoma cells18
Effect of PR status on the prognosis of advanced ER-high HER2-negative breast cancer patients receiving CDK4/6 inhibitor combined with endocrine as first-line therapy18
Health-related risk behaviors among U.S. childhood cancer survivors: a nationwide estimate18
Stepwise correlation of TP53 mutations from pancreaticobiliary maljunction to gallbladder carcinoma: a retrospective study18
Transcutaneous canine breast cancer detection in Tunisia: a pilot study18
LncRNA SH3PXD2A-AS1 facilitates cisplatin resistance in non-small cell lung cancer by regulating FOXM1 succinylation18
Efficacy of donepezil for the treatment of oxaliplatin-induced peripheral neuropathy: DONEPEZOX, a protocol of a proof of concept, randomised, triple-blinded and multicentre trial18
0.056439876556396